| 1 |
33497758 | Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer. | 2021 Apr |
2 |
| 2 |
32111984 | SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. | 2020 Apr |
3 |
| 3 |
30412912 | Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib. | 2019 Feb |
1 |
| 4 |
30863492 | Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer. | 2019 Feb 12 |
1 |
| 5 |
31280674 | Discovery of novel 1,2,4-triazolo-1,2,4-triazines with thiomethylpyridine hinge binders as potent c-Met kinase inhibitors. | 2019 May |
1 |
| 6 |
30333869 | Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells. | 2018 Nov |
1 |
| 7 |
28075018 | C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives. | 2017 Oct |
1 |
| 8 |
28474864 | Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway. | 2017 Jul |
1 |
| 9 |
28498406 | Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer. | 2017 Jul |
1 |
| 10 |
28819999 | High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium. | 2017 Dec |
1 |
| 11 |
29125233 | In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. | 2017 Dec |
1 |
| 12 |
25775951 | Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway. | 2015 Aug |
1 |
| 13 |
26345996 | Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma. | 2015 |
1 |
| 14 |
26496080 | Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. | 2015 |
1 |
| 15 |
24722154 | High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer. | 2014 May |
1 |
| 16 |
24828661 | Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation. | 2014 Jun |
1 |
| 17 |
23962905 | Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells. | 2013 Nov |
6 |
| 18 |
24118504 | Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. | 2013 Dec |
1 |
| 19 |
22683780 | Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. | 2012 Jul |
1 |